Scandion Oncology (Scandion) will publish its Q2 2022 interim report on Thursday, August 25, 2022 before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Thursday August 25, 2022 at 10:00 CET https://financialhearings.com/event/43548
Meet Scandion Oncology at LSX Nordic 2022
Our Executive Management will host a webcast and conference call.
We will give a presentation and update on Scandion followed by a Q&A session Read more Download presentation
We will give a presentation and update on Scandion followed by a Q&A session. Watch the presentation here
We will give a presentation and update on Scandion followed by a Q&A session.
We will give a presentation and update on Scandion followed by a Q&A session. Watch replay
Scandion Oncology will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://financialhearings.com/event/45864 Dial-in: DK: +4578150110 SE: +46850558354 UK: +443333009266 US: +1 6319131422 PIN US: 42830998# REPLAY access Webcast replay will be available at http://www.scandiononcology.com in the Investors section and at http://www.financialhearings.com For further information please contact: Johnny Stilou, Acting CEO & CFO Phone: +45 2960 3532 E-mail: jos@scandiononcology.com
Watch the presentation here. We will give a presentation and update on Scandion followed by a Q&A session.
Webcast for this event can be found here
Meet Scandion Oncology at Swiss Nordic Bio 2023
